Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Comment by Leafs4Lifeon Nov 28, 2017 3:33pm
241 Views
Post# 27048509

RE:RE:RE:New Investors

RE:RE:RE:New InvestorsThe company will release sales information in early December (second week) as soon as the final tally for November (and one week of October) is complete. Investor relations is telling this to anyone who will listen.  If you don't beleive me, give them a call 604 417 6400

Since the CEO forecast $1 million in revenue for 2017, I expect the revenue number for November to come in somewhere between $400k and $500k.  Any surprise to the upside should be bought aggressively because it means there is greater demand for their products than the company originally thought. All subsequent revenue projections should be revised to the upside.

In one of the videos the CEO mentioned that they had sourced 2000 metric tonnes of biomass (2000 Kilos) from which they will extract oil to be used in strips and cartriges. Then last week they took out a loan to secure $500k more organic biomass. I view the loan is a bullish signal that the demand for their strips and cartriges is robust. Presumably, they could have financed the purchase of biomass from busienss activities once they collected payment on their first run of products. Instead, they expanded capacity by taking on debt to buy more source material which they will convert into products and sell at a healthy margin. 

We will know more in early December when they release sales numbers.  Tomorrow they are scheduled to release their earnings for the prior quarter. Aside from reading the MD&A I will take great interest in their cash balance. If they had $1.5 million or more on the books as of September 30th I think we can put to bed the rumour that LDS will be raising cash anytime soon. With healthy cashflow and over a million in the bank they should be able to secure a line of credit to complete their grow facility (which will be built in a modular fashion).    


JD2016 wrote: I haven't come across any material that discloses that information maybe someone else on this board can share this information if they have it but i do know it was indicated that we will get information on sales since production in early December 




Bullboard Posts